Lv1
76 积分 2023-07-01 加入
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
1个月前
已完结
JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1
1个月前
已完结
Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma
1个月前
已完结
FXR–YAP signalling maintains biliary epithelial cell identity and preserves liver homeostasis
2个月前
已完结
Cholangiocyte Biology in Primary Sclerosing Cholangitis and Other Cholangiopathies: Pathogenesis, Clinical Insights, and Experimental Tools
2个月前
已关闭
A pig model of human radiation-induced veno-occlusive liver disease reveals ferroptosis as a therapeutic target
2个月前
已关闭
A Gut-Restricted Liver X Receptor Agonist Ameliorates Liver Injury in Experimental Short Bowel Syndrome
3个月前
已完结
Targeting APE1-Redox Function Reverses SOX9-mediated Chemoresistance in Esophageal Adenocarcinoma
3个月前
已完结
Pre-operative risk assessment of HCC recurrence in liver transplant recipients by non-invasive detection of pre-existing genetic lesions
4个月前
已完结
Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar Carcinoma
4个月前
已关闭
皖公网安备34019202002308
